FTC OKs Actavis' $8B Warner Chilcott Buy With Conditions
Actavis Inc. said Friday that it has agreed to sell rights to three oral contraceptives and an osteoporosis treatment to a New Jersey-based pharmaceutical company in order to settle Federal Trade...To view the full article, register now.
Already a subscriber? Click here to view full article